Hong Kong Stock Movement: GF HEALTHCARE fell 13.71%
GF HEALTHCARE fell 13.71%; Baize Medical fell 8.47%, with a transaction volume of HKD 367 million; Haijia Medical fell 0.85%, with a transaction volume of HKD 37.42 million; China Resources Medical fell 0.82%, with a transaction volume of HKD 5.71 million; Shengbeila fell 2.43%, with a market value of HKD 3.995 billion
Hong Kong Stock Movement
Stocks with High Trading Volume in the Industry
Haijia Medical fell 0.85%. According to recent key news:
-
On September 15, Zhongtai International pointed out that the control of medical insurance costs still affects the performance of traditional medical service companies in Hong Kong, and Haijia Medical's profits have declined year-on-year. Government policies have been introduced to alleviate the funding issues of medical institutions, and the operating environment is expected to improve.
-
On September 15, the Trump administration stated that it would strengthen the review of authorized transactions for innovative drugs from China, which may affect Chinese pharmaceutical companies' overseas transactions.
-
On September 15, the introduction of the commercial insurance innovative drug catalog is beneficial for the sales of high-priced innovative drugs, and the demand for innovative drug research and development has increased, which is favorable for CXO sector companies. The Hong Kong medical sector is affected by policies
